The abstract is read at the publisher; the summary is JClub's.
Direct intracellular delivery of KRAB-ZF-Myb protein to Jurkat T-ALL cells reduces TAL1 expression and cell proliferation, with a four-fold affinity gain from KRAB.
- Why it matters: TAL1 overexpression in T-ALL is linked to MYB-driven super-enhancer activity, so disrupting the TAL1–MYB oncogenic axis could suppress leukemia programs.
- What they did: In Jurkat cells, synthetic zinc finger proteins targeting the MYB binding site (ZF-Myb) were delivered as proteins, with KRAB increasing DNA-binding affinity four-fold and CATCH peptides enhancing granule formation.
- The result: KRAB-ZF-Myb protein delivery downregulates TAL1, disrupts the TAL1–MYB axis, and induces pro-apoptotic gene expression, enabling a targeted protein-delivery strategy for T-ALL.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.